PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 87 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,326,760 | -48.5% | 139,494 | -14.6% | 0.01% | -47.8% |
| Q2 2023 | $4,513,799 | +60.8% | 163,425 | +33.9% | 0.02% | +53.3% |
| Q1 2023 | $2,806,552 | +32.1% | 122,024 | -37.3% | 0.02% | +25.0% |
| Q4 2022 | $2,124,221 | +31.8% | 194,704 | +1.8% | 0.01% | +9.1% |
| Q3 2022 | $1,612,000 | +219.2% | 191,193 | +568.6% | 0.01% | +175.0% |
| Q2 2020 | $505,000 | – | 28,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 750,632 | $7,724,000 | 26.59% |
| BVF INC/IL | 2,617,967 | $26,939,000 | 2.37% |
| GREAT POINT PARTNERS LLC | 982,449 | $10,109,000 | 1.58% |
| Alambic Investment Management, L.P. | 65,128 | $670,000 | 0.53% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,243,202 | $23,083,000 | 0.14% |
| ALGERT GLOBAL LLC | 44,477 | $458,000 | 0.10% |
| Monashee Investment Management LLC | 42,945 | $442,000 | 0.09% |
| Tekla Capital Management LLC | 219,042 | $2,254,000 | 0.08% |
| Spark Investment Management LLC | 138,800 | $1,428,000 | 0.08% |
| OXFORD ASSET MANAGEMENT LLP | 187,653 | $1,904,000 | 0.04% |